NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

骨形成蛋白的全球市場:各類型,各應用領域的預測(到2025年)- COVID-19累積的影響

Bone Morphogenetic Protein Market Research Report by Type, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1001090
出版日期 內容資訊 英文 194 Pages
商品交期: 最快1-2個工作天內
價格
骨形成蛋白的全球市場:各類型,各應用領域的預測(到2025年)- COVID-19累積的影響 Bone Morphogenetic Protein Market Research Report by Type, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 194 Pages
簡介

全球骨形成蛋白的市場規模預測將從2020年的10億9,267萬美元,擴大到2025年末的20億8,367萬美元。

COVID-19是前所未有的全球性公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們窮究潛在的COVID-19問題和未來路徑。該報告考慮了消費者行為和需求的變化,購買方式,供應鏈的重新改道,當前市場趨勢以及政府的重要介入等因素,提供有關COVID-19的洞察。

本報告提供全球骨形成蛋白市場的相關調查,提供市場機會和課題,成長及阻礙因素,COVID-19累積的影響,類型·應用·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

  • 調查目的
  • 市場區隔和涵蓋範圍
  • 調查期間
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查方法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 製作計劃:調查計劃
    • 實施實行:調查
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查的成果

第3章 摘要整理

  • 市場展望
  • 各類型市場展望
  • 各應用領域市場展望
  • 各地區市場的展望
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析

第6章 各類型市場

  • rhBMP-2
  • rhBMP-7

第7章 各應用領域市場

  • 口腔下巴臉外科手術
  • 重組術
  • 脊椎融合手術
  • 外傷治療

第8章 南北美洲市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章 歐洲,中東·非洲市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第11章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併·收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 評估,認識,擴大

第12章 企業簡介

  • Akron Biotechnology, LLC
  • AlloSource, Inc.
  • Cellumed Co. Ltd
  • Ember Therapeutics Inc.
  • Hangzhou Jiuyuan Gene Engineering Co .,Ltd
  • Integra Lifesciences Holdings Corporation
  • Johnson & Johnson Services Inc
  • Medtronic PLC
  • Merck Group
  • Olympus Biotech Corporation
  • Pfizer, Inc.
  • Prospec-Tany Technogene Ltd.
  • R&D Systems, Inc.
  • Sino Biological Inc.
  • Smith and Nephew, Inc.
  • Thermo Fisher Scientific, Inc
  • Xtant Medical Holdings, Inc
  • Zimmer Biomet Holdings, Inc.

第13章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-ED54C46E81FC

The Global Bone Morphogenetic Protein Market size was estimated at USD 1,092.67 Million in 2020 and expected to reach USD 1,248.70 Million in 2021, at a Compound Annual Growth Rate (CAGR) 14.61% to reach USD 2,477.57 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Bone Morphogenetic Protein to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type , the Bone Morphogenetic Protein Market was studied across rhBMP-2 and rhBMP-7.

Based on Application , the Bone Morphogenetic Protein Market was studied across Oral Maxillofacial, Reconstruction, Spinal fusion, and Trauma.

Based on Geography, the Bone Morphogenetic Protein Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Bone Morphogenetic Protein Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Bone Morphogenetic Protein Market, including Akron Biotechnology, LLC, AlloSource, Inc., Cellumed Co. Ltd, Ember Therapeutics Inc., Hangzhou Jiuyuan Gene Engineering Co .,Ltd, Integra Lifesciences Holdings Corporation, Johnson & Johnson Services Inc, Medtronic PLC, Merck Group, Olympus Biotech Corporation, Pfizer, Inc., Prospec-Tany Technogene Ltd., R&D Systems, Inc., Sino Biological Inc., Smith and Nephew, Inc., Thermo Fisher Scientific, Inc, Xtant Medical Holdings, Inc, and Zimmer Biomet Holdings, Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Bone Morphogenetic Protein Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bone Morphogenetic Protein Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bone Morphogenetic Protein Market?
  • 4. What is the competitive strategic window for opportunities in the Global Bone Morphogenetic Protein Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Bone Morphogenetic Protein Market?
  • 6. What is the market share of the leading vendors in the Global Bone Morphogenetic Protein Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Bone Morphogenetic Protein Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Type Outlook
  • 3.4. Application Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence rate of sports-related injuries and spinal fusion procedure
      • 5.1.1.2. Increasing awareness regarding the bone morphogenetic protein
      • 5.1.1.3. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the procedure
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing demand for minimally invasive medical procedures
      • 5.1.3.2. Developing advancements in treatment lines for traumatic injuries
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of the substitute treatment and products such as bone grafts and scaffolds
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Bone Morphogenetic Protein Market, by Type

  • 6.1. Introduction
  • 6.2. rhBMP-2
  • 6.3. rhBMP-7

7. Bone Morphogenetic Protein Market, by Application

  • 7.1. Introduction
  • 7.2. Oral Maxillofacial
  • 7.3. Reconstruction
  • 7.4. Spinal fusion
  • 7.5. Trauma

8. Americas Bone Morphogenetic Protein Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Bone Morphogenetic Protein Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Bone Morphogenetic Protein Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Akron Biotechnology, LLC
  • 12.2. AlloSource, Inc.
  • 12.3. Cellumed Co. Ltd
  • 12.4. Ember Therapeutics Inc.
  • 12.5. Hangzhou Jiuyuan Gene Engineering Co .,Ltd
  • 12.6. Integra Lifesciences Holdings Corporation
  • 12.7. Johnson & Johnson Services Inc
  • 12.8. Medtronic PLC
  • 12.9. Merck Group
  • 12.10. Olympus Biotech Corporation
  • 12.11. Pfizer, Inc.
  • 12.12. Prospec-Tany Technogene Ltd.
  • 12.13. R&D Systems, Inc.
  • 12.14. Sino Biological Inc.
  • 12.15. Smith and Nephew, Inc.
  • 12.16. Thermo Fisher Scientific, Inc
  • 12.17. Xtant Medical Holdings, Inc
  • 12.18. Zimmer Biomet Holdings, Inc.

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2020 (USD MILLION)
  • FIGURE 3. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2020 (USD MILLION)
  • FIGURE 4. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2020 VS 2026 (USD MILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2026
  • FIGURE 10. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RHBMP-2, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RHBMP-2, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RHBMP-7, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RHBMP-7, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2020 VS 2026 (%)
  • FIGURE 15. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2020 VS 2026 (USD MILLION)
  • FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2026
  • FIGURE 17. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY ORAL MAXILLOFACIAL, 2018-2026 (USD MILLION)
  • FIGURE 18. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY ORAL MAXILLOFACIAL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RECONSTRUCTION, 2018-2026 (USD MILLION)
  • FIGURE 20. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RECONSTRUCTION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY SPINAL FUSION, 2018-2026 (USD MILLION)
  • FIGURE 22. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY SPINAL FUSION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TRAUMA, 2018-2026 (USD MILLION)
  • FIGURE 24. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TRAUMA, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 26. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 28. ARGENTINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 29. BRAZIL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 30. CANADA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 31. MEXICO BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 32. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 33. CALIFORNIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 34. FLORIDA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 35. ILLINOIS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 36. NEW YORK BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 37. OHIO BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. PENNSYLVANIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. TEXAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 41. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 43. CHINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. INDIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. INDONESIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. JAPAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. MALAYSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. PHILIPPINES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. SOUTH KOREA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. THAILAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 52. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 54. FRANCE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. GERMANY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. ITALY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. NETHERLANDS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. QATAR BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. RUSSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. SAUDI ARABIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. SOUTH AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. SPAIN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. UNITED ARAB EMIRATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. UNITED KINGDOM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: FPNV POSITIONING MATRIX
  • FIGURE 66. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 67. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 68. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BONE MORPHOGENETIC PROTEIN MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RHBMP-2, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RHBMP-7, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY ORAL MAXILLOFACIAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RECONSTRUCTION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY SPINAL FUSION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TRAUMA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. ARGENTINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. ARGENTINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. BRAZIL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. BRAZIL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. CANADA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. CANADA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. MEXICO BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. MEXICO BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. CALIFORNIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. CALIFORNIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. FLORIDA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. FLORIDA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. ILLINOIS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. ILLINOIS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. NEW YORK BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. NEW YORK BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. OHIO BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. OHIO BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. PENNSYLVANIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. PENNSYLVANIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. TEXAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. TEXAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. CHINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. CHINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. INDIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. INDIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. INDONESIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. INDONESIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. JAPAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. JAPAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. MALAYSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. MALAYSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. PHILIPPINES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. PHILIPPINES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. SOUTH KOREA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. SOUTH KOREA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. THAILAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. THAILAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. FRANCE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. FRANCE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. GERMANY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. GERMANY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. ITALY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. ITALY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. NETHERLANDS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. NETHERLANDS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. QATAR BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. QATAR BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. RUSSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. RUSSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. SAUDI ARABIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. SAUDI ARABIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. SOUTH AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. SOUTH AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. SPAIN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. SPAIN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. UNITED ARAB EMIRATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. UNITED ARAB EMIRATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. UNITED KINGDOM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. UNITED KINGDOM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: SCORES
  • TABLE 84. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: BUSINESS STRATEGY
  • TABLE 85. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: PRODUCT SATISFACTION
  • TABLE 86. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: RANKING
  • TABLE 87. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 88. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: SHARE, BY COMPANY, 2020
  • TABLE 89. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: MERGER & ACQUISITION
  • TABLE 90. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 91. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 92. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: INVESTMENT & FUNDING
  • TABLE 93. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 94. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: LICENSE & PRICING
  • TABLE 95. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: CONTACT DETAILS